BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

953 related articles for article (PubMed ID: 23669226)

  • 21. [A concept of regulating tumor microenvironment immune and normalizing angiogenesis by Chinese medicine drug therapy for supporting zheng-qi to prop up root].
    Xiong L; Tian SX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Feb; 30(2):201-4. PubMed ID: 20462053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Regular Physical Exercise in Tumor Vasculature: Favorable Modulator of Tumor Milieu.
    Esteves M; Monteiro MP; Duarte JA
    Int J Sports Med; 2021 May; 42(5):389-406. PubMed ID: 33307553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular normalization as an emerging strategy to enhance cancer immunotherapy.
    Huang Y; Goel S; Duda DG; Fukumura D; Jain RK
    Cancer Res; 2013 May; 73(10):2943-8. PubMed ID: 23440426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor Vasculatures: A New Target for Cancer Immunotherapy.
    Liu Z; Wang Y; Huang Y; Kim BYS; Shan H; Wu D; Jiang W
    Trends Pharmacol Sci; 2019 Sep; 40(9):613-623. PubMed ID: 31331639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting tumor vascularization: promising strategies for vascular normalization.
    Zheng R; Li F; Li F; Gong A
    J Cancer Res Clin Oncol; 2021 Sep; 147(9):2489-2505. PubMed ID: 34148156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metronomic scheduling of anticancer treatment: the next generation of multitarget therapy?
    André N; Padovani L; Pasquier E
    Future Oncol; 2011 Mar; 7(3):385-94. PubMed ID: 21417902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vessel pruning or healing: endothelial metabolism as a novel target?
    Cantelmo AR; Pircher A; Kalucka J; Carmeliet P
    Expert Opin Ther Targets; 2017 Mar; 21(3):239-247. PubMed ID: 28081641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiogenesis as a hallmark of solid tumors - clinical perspectives.
    Majidpoor J; Mortezaee K
    Cell Oncol (Dordr); 2021 Aug; 44(4):715-737. PubMed ID: 33835425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiangiogenic therapy for cancer: current and emerging concepts.
    Jain RK
    Oncology (Williston Park); 2005 Apr; 19(4 Suppl 3):7-16. PubMed ID: 15934498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visualizing vasculature and its response to therapy in the tumor microenvironment.
    Lin Q; Choyke PL; Sato N
    Theranostics; 2023; 13(15):5223-5246. PubMed ID: 37908739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of the tumor vasculature and oxygenation to improve therapy.
    Siemann DW; Horsman MR
    Pharmacol Ther; 2015 Sep; 153():107-24. PubMed ID: 26073310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiogenesis and tumor microenvironment: bevacizumab in the breast cancer model.
    Trédan O; Lacroix-Triki M; Guiu S; Mouret-Reynier MA; Barrière J; Bidard FC; Braccini AL; Mir O; Villanueva C; Barthélémy P
    Target Oncol; 2015 Jun; 10(2):189-98. PubMed ID: 25185646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shaping Tumor Microenvironment for Improving Nanoparticle Delivery.
    Gao H
    Curr Drug Metab; 2016; 17(8):731-736. PubMed ID: 27396754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-angiogenic nano-delivery system promotes tumor vascular normalizing and micro-environment reprogramming in solid tumor.
    Shen R; Peng L; Zhou W; Wang D; Jiang Q; Ji J; Hu F; Yuan H
    J Control Release; 2022 Sep; 349():550-564. PubMed ID: 35841997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiangiogenic therapy improves the antitumor effect of adoptive cell immunotherapy by normalizing tumor vasculature.
    Shi S; Chen L; Huang G
    Med Oncol; 2013 Dec; 30(4):698. PubMed ID: 23982676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiangiogenic therapy: a novel approach to overcome tumor hypoxia.
    Peng F; Chen M
    Chin J Cancer; 2010 Aug; 29(8):715-20. PubMed ID: 20663317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent Advances in Strategies for Extracellular Matrix Degradation and Synthesis Inhibition for Improved Therapy of Solid Tumors.
    Sandha KK; Shukla MK; Gupta PN
    Curr Pharm Des; 2020; 26(42):5456-5467. PubMed ID: 32723249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tranilast-induced stress alleviation in solid tumors improves the efficacy of chemo- and nanotherapeutics in a size-independent manner.
    Papageorgis P; Polydorou C; Mpekris F; Voutouri C; Agathokleous E; Kapnissi-Christodoulou CP; Stylianopoulos T
    Sci Rep; 2017 Apr; 7():46140. PubMed ID: 28393881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy.
    Yang S; Gao H
    Pharmacol Res; 2017 Dec; 126():97-108. PubMed ID: 28501517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.